Literature DB >> 28368494

Multi-omics Based Identification of Specific Biochemical Changes Associated With PfKelch13-Mutant Artemisinin-Resistant Plasmodium falciparum.

Ghizal Siddiqui1, Anubhav Srivastava1, Adrian S Russell1, Darren J Creek1.   

Abstract

Background: The emergence of artemisinin resistance in the malaria parasite Plasmodium falciparum poses a major threat to the control and elimination of malaria. Certain point mutations in the propeller domain of PfKelch13 are associated with resistance, but PfKelch13 mutations do not always result in clinical resistance. The underlying mechanisms associated with artemisinin resistance are poorly understood, and the impact of PfKelch13 mutations on cellular biochemistry is not defined.
Methods: This study aimed to identify global biochemical differences between PfKelch13-mutant artemisinin-resistant and -sensitive strains of P. falciparum by combining liquid chromatography-mass spectrometry (LC-MS)-based proteomics, peptidomics, and metabolomics.
Results: Proteomics analysis found both PfKelch13 mutations examined to be specifically associated with decreased abundance of PfKelch13 protein. Metabolomics analysis demonstrated accumulation of glutathione and its precursor, gamma-glutamylcysteine, and significant depletion of 1 other putative metabolite in resistant strains. Peptidomics analysis revealed lower abundance of several endogenous peptides derived from hemoglobin (HBα and HBβ) in the artemisinin-resistant strains.
Conclusion: PfKelch13 mutations associated with artemisinin resistance lead to decreased abundance of PfKelch13 protein, decreased hemoglobin digestion, and enhanced glutathione production.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.

Entities:  

Keywords:  PfKelch13; Plasmodium falciparum; artemisinin resistance; malaria; metabolomics; peptidomics.; proteomics

Mesh:

Substances:

Year:  2017        PMID: 28368494     DOI: 10.1093/infdis/jix156

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

Review 1.  Elucidating Mechanisms of Drug-Resistant Plasmodium falciparum.

Authors:  Leila S Ross; David A Fidock
Journal:  Cell Host Microbe       Date:  2019-07-10       Impact factor: 21.023

2.  Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum.

Authors:  Geoffrey W Birrell; Matthew P Challis; Amanda De Paoli; Dovile Anderson; Shane M Devine; Gavin D Heffernan; David P Jacobus; Michael D Edstein; Ghizal Siddiqui; Darren J Creek
Journal:  Mol Cell Proteomics       Date:  2019-12-13       Impact factor: 5.911

3.  Modification of pfap2μ and pfubp1 Markedly Reduces Ring-Stage Susceptibility of Plasmodium falciparum to Artemisinin In Vitro.

Authors:  Ryan C Henrici; Donelly A van Schalkwyk; Colin J Sutherland
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

4.  A new mass spectral library for high-coverage and reproducible analysis of the Plasmodium falciparum-infected red blood cell proteome.

Authors:  Ghizal Siddiqui; Amanda De Paoli; Christopher A MacRaild; Anna E Sexton; Coralie Boulet; Anup D Shah; Mitchell B Batty; Ralf B Schittenhelm; Teresa G Carvalho; Darren J Creek
Journal:  Gigascience       Date:  2022-03-07       Impact factor: 6.524

5.  Dynamic Protein Corona of Gold Nanoparticles with an Evolving Morphology.

Authors:  Aparna Nandakumar; Wei Wei; Ghizal Siddiqui; Huayuan Tang; Yuhuan Li; Aleksandr Kakinen; Xulin Wan; Kairi Koppel; Sijie Lin; Thomas P Davis; David T Leong; Darren J Creek; Feng Ding; Yang Song; Pu Chun Ke
Journal:  ACS Appl Mater Interfaces       Date:  2021-11-19       Impact factor: 9.229

Review 6.  Recent metabolomic developments for antimalarial drug discovery.

Authors:  Lúcia Mamede; Fanta Fall; Matthieu Schoumacher; Allison Ledoux; Pascal De Tullio; Joëlle Quetin-Leclercq; Michel Frédérich
Journal:  Parasitol Res       Date:  2022-10-04       Impact factor: 2.383

7.  Dimeric Artesunate Glycerophosphocholine Conjugate Nano-Assemblies as Slow-Release Antimalarials to Overcome Kelch 13 Mutant Artemisinin Resistance.

Authors:  Xinsong Li; Leann Tilley; Yawei Du; Carlo Giannangelo; Wei He; Gerald J Shami; Wenya Zhou; Tuo Yang; Darren J Creek; Con Dogovski
Journal:  Antimicrob Agents Chemother       Date:  2022-04-13       Impact factor: 5.938

8.  A Proteasome Mutation Sensitizes P. falciparum Cam3.II K13C580Y Parasites to DHA and OZ439.

Authors:  Melissa R Rosenthal; Caroline L Ng
Journal:  ACS Infect Dis       Date:  2021-05-10       Impact factor: 5.578

Review 9.  Artemisinin susceptibility in the malaria parasite Plasmodium falciparum: propellers, adaptor proteins and the need for cellular healing.

Authors:  Colin J Sutherland; Ryan C Henrici; Katerina Artavanis-Tsakonas
Journal:  FEMS Microbiol Rev       Date:  2021-05-05       Impact factor: 16.408

10.  Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness.

Authors:  Barbara H Stokes; Satish K Dhingra; Kelly Rubiano; Sachel Mok; Judith Straimer; Nina F Gnädig; Ioanna Deni; Kyra A Schindler; Jade R Bath; Kurt E Ward; Josefine Striepen; Tomas Yeo; Leila S Ross; Eric Legrand; Frédéric Ariey; Clark H Cunningham; Issa M Souleymane; Adama Gansané; Romaric Nzoumbou-Boko; Claudette Ndayikunda; Abdunoor M Kabanywanyi; Aline Uwimana; Samuel J Smith; Olimatou Kolley; Mathieu Ndounga; Marian Warsame; Rithea Leang; François Nosten; Timothy Jc Anderson; Philip J Rosenthal; Didier Ménard; David A Fidock
Journal:  Elife       Date:  2021-07-19       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.